OS-9 Inhibitors
OS-9 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of **OS-9**, a protein involved in the endoplasmic reticulum-associated degradation (ERAD) pathway. OS-9 plays a critical role in identifying and binding misfolded or improperly processed glycoproteins within the endoplasmic reticulum (ER), tagging them for degradation via the ubiquitin-proteasome system. By binding to the OS-9 protein, inhibitors disrupt its ability to recognize and process misfolded proteins, thus affecting the proper functioning of the ERAD pathway. This inhibition allows researchers to study how cells manage protein quality control and how the disruption of this system impacts cellular homeostasis, particularly in the context of protein folding and degradation.
Research into OS-9 inhibitors provides valuable insights into the broader mechanisms of protein quality control within cells. By blocking OS-9 activity, scientists can observe the buildup of misfolded proteins and examine how cells respond to an overload of improperly folded proteins within the ER. This helps to uncover how cells manage protein folding stress and maintain cellular function under conditions where protein homeostasis is disrupted. Additionally, OS-9 inhibitors serve as tools to explore the connections between protein degradation pathways and other cellular processes, such as ER stress responses, signaling pathways, and overall protein metabolism. Through these studies, OS-9 inhibitors contribute to a deeper understanding of the molecular machinery that governs protein quality control and its importance in maintaining cellular integrity and functionality.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin may decrease OS-9 expression by depleting ER calcium stores, escalating ER stress, and consequently initiating UPR pathways that attenuate the synthesis of proteins including OS-9. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
As an Hsp90 inhibitor, 17-AAG could indirectly decrease OS-9 levels by disrupting the proper folding of proteins that associate with OS-9, thus destabilizing its expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG might downregulate OS-9 by inhibiting the heat shock response, which is critical for the proper function of molecular chaperones involved in protein maturation, including those related to the ERAD pathway. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
By inhibiting DNA-dependent RNA polymerase, rifampicin could reduce OS-9 expression by decreasing overall transcriptional activity within the cell, including genes involved in ER stress response. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine could decrease OS-9 expression by disrupting lysosomal acidification and autophagic flux, leading to altered cellular degradation pathways, which may include the ERAD process involving OS-9. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin may reduce OS-9 expression by inhibiting Hsp90 chaperone activity, leading to a destabilization of its client proteins and potentially impairing the ERAD mechanism where OS-9 functions. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin could inhibit OS-9 synthesis by causing premature chain termination during mRNA translation, which would result in the reduction of overall protein levels, including OS-9. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C might inhibit OS-9 expression by cross-linking DNA, which would interfere with DNA replication and transcription, leading to a decrease in the production of various proteins, including ER stress-related ones. | ||||||
β-Lapachone | 4707-32-8 | sc-200875 sc-200875A | 5 mg 25 mg | $112.00 $459.00 | 8 | |
β-Lapachone could downregulate OS-9 through the generation of reactive oxygen species (ROS), which might trigger an antioxidant response that inadvertently reduces the expression of proteins implicated in the ERAD pathway. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram may inhibit OS-9 expression by interfering with proteasome activity, leading to the accumulation of misfolded proteins and potentially a compensatory reduction in the expression of ERAD components. | ||||||